Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 25:13:1622566.
doi: 10.3389/fchem.2025.1622566. eCollection 2025.

Application of nano and microformulations to improve the leishmanicidal response of quinoline compounds: a brief review

Angel H Romero  1 , Karina N Gonzalez  2   3 , Marcos A Sabino  4
Affiliations
Review

Application of nano and microformulations to improve the leishmanicidal response of quinoline compounds: a brief review

Angel H Romero et al. Front Chem. .

Abstract

The quinolines represent an important scaffold for the development of leishmanicidal agents. In particular, the use of nano and microformulations has emerged as a powerful tool to improve the therapeutic profile of leishmanicidal drugs, favoring bioavailability, transportation to key targets, metabolic protection, and immunostimulating responses. This mini-review seeks to provide a general perspective about the use of nano/microencapsulation for the development of leishmanicidal formulations based on quinoline, giving an overview of the various cases of encapsulation, analyzing the repercussions of the type of polymeric matrix (synthetic or natural polymer), type of formulation (polymeric or metallic nanoparticles, micelles, liposomes, etc.), drug loading percentage, and release rate of quinoline drug.

Keywords: DDS; amastigote; leishmania; leishmanicidal agent; nanoparticles; quinoline drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Main type of nanosystems; (B) structure of synthetic (PIHCA, PLA, PEG, and PLGA), surfactant (poloxamer 407), and natural (chitosan, cellulose, and BSA) biopolymers for nanoencapsulation of leishmanicidal quinolines 1–8; and (C) structure of leishmanicidal quinolines used for DDS.
See this image and copyright information in PMC

References

    1. Akbaria M., Oryanb A., Hatam G. (2017). Application of nanotechnology in treatment of leishmaniasis: a Review. Acta Trop. 172, 86–90. 10.1016/j.actatropica.2017.04.029 - DOI - PubMed
    1. Allotey-Babington G. L., Nettey H., Ofori Gyamera N. K., Goode N. A., Mensah A. A., Asiedu-Gyekye I. J., et al. (2024). Development and evaluation of an oral quinine sulphate sustained release formulation for the management of visceral leishmaniasis. Int. J. Res. Pharm. Sci. 15, 48–55. 10.26452/ijrps.v15i4.4720 - DOI
    1. Allotey-Babington G. L., Sasu C., Nettey H., Nettey H. (2020). Quinine sulphate microparticles as treatment for leishmaniasis. Hind J. Trop. Med. 2020, 1–9. 10.1155/2020/5278518 - DOI - PMC - PubMed
    1. Aronson N., Herwaldt B. L., Libman M., Pearson R., Lopez-Velez R., Weina P., et al. (2016). Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American society of tropical medicine and hygiene (ASTMH). Clin. Inf. Dis. 63, e202–e264. 10.1093/cid/ciw670 - DOI - PubMed
    1. Avanzo R. E., García Liñares G., Rodríguez N., Romero A. H. (2025). A comprehensive revision on the use of quinoline antimalarial drugs as leishmanicidal agents. Front. Chem. 13, 1608340. 10.3389/fchem.2025.1608340 - DOI - PMC - PubMed

LinkOut - more resources